-
A COMMON MODELING FRAMEWORK FOR ONCOLOGY COST-EFFECTIVENESS ANALYSES ACROSS THREE DIFFERENT CANCER TYPES
Aug 11, 2026, 17:15 PM -
LONGITUDINAL EXUDATE BURDEN AND DELAYED HEALING IN VENOUS LEG ULCERS: A REAL-WORLD ELECTRONIC HEALTH RECORD ANALYSIS
Aug 11, 2026, 17:15 PM -
STRUCTURED ONCOLOGY LITERATURE SCREENING AS THE METHODOLOGICAL FOUNDATION FOR EU JOINT CLINICAL ASSESSMENT PREPARATION AND TARGET TRIAL EMULATION PLANNING
Aug 11, 2026, 17:15 PM -
PHARMACOECONOMIC EVALUATION OF A DIFFERENTIATED DRUG SCREENING PROGRAM IN ALGERIA: A COST-CONSEQUENCE ANALYSISPHARMACOECONOMIC EVALUATION OF A DIFFERENTIATED DRUG SCREENING PROGRAM IN ALGERIA: A COST-CONSEQUENCE ANALYSIS
Aug 11, 2026, 17:15 PM -
BENCHMARKING AS A TOOL FOR ASSESSING CROSS-COUNTRY COMPARABILITY OF SURVIVAL EVIDENCE FOR HTA
Aug 11, 2026, 17:15 PM -
THE HIDDEN ECONOMIC AND HEALTHCARE BURDEN OF NAMD IN THE USA AND GERMANY EVIDENCE FROM A 20-YEAR SOCIAL IMPACT MODEL
Aug 11, 2026, 17:15 PM -
COST-UTILITY ANALYSIS FROM VARYING RATES OF SCREENING AND FOLLOW-UP COLONOSCOPY: REAL-WORLD ANALYSIS OF TAIWAN COLORECTAL CANCER SCREENING PROGRAM
Aug 11, 2026, 17:15 PM -
BUDGET IMPACT ANALYSIS OF SOUVENAID FOR THE MANAGEMENT OF ALZHEIMER'S DISEASE IN MIDDLE EAST AND NORTH AFRICA REGION
Aug 11, 2026, 17:15 PM -
HOW HAVE PRICES ACROSS THERAPY AREAS AND COUNTRIES EVOLVED OVER THE LAST 5 YEARS AND WHAT IMPACT CAN WE EXPECT PRICE REFERENCING POLICIES SUCH AS MFN TO HAVE IN THE FUTURE?
Aug 11, 2026, 17:15 PM -
LONG-TERM REAL-WORLD PATIENT-REPORTED OUTCOMES AND URGENCY ON ADALIMUMAB IN ULCERATIVE COLITIS: 36-MONTH TRAJECTORIES FROM THE AMPERSAND DIGITAL COHORT
Aug 11, 2026, 17:15 PM -
ASSOCIATION BETWEEN VASOMOTOR SYMPTOM RESPONSE AND EQ-5D IN WOMEN WITH BREAST CANCER EXPERIENCING MODERATE-TO-SEVERE VASOMOTOR SYMPTOMS CAUSED BY ADJUVANT ENDOCRINE THERAPY
Aug 11, 2026, 17:15 PM -
HOW NATIONAL HTA SYSTEMS ARE BEING RESHAPED IN RESPONSE TO EU HTA: A REVIEW OF CURRENT REFORMS AND EARLY IMPLEMENTATION
Aug 11, 2026, 17:15 PM -
CLINICAL UTILITY OF ENHANCED LIVER FIBROSIS (ELF)-GUIDED REFERRAL STRATEGIES: A DECISION CURVE ANALYSIS IN US VETERANS
Aug 11, 2026, 17:15 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH NON-SURGICAL AND POST-SURGICAL HYPOPARATHYROIDISM: A REAL-WORLD CLAIMS ANALYSIS
Aug 11, 2026, 17:15 PM -
ASSESSING EUROPEAN REIMBURSEMENT FRICTION AND PRIVATE ACCESS RELIANCE ACROSS THERAPEUTIC AREAS
Aug 11, 2026, 17:15 PM -
SOCIETAL ECONOMIC BURDEN OF GENE AND CELL THERAPY-RELEVANT DISEASES IN GERMANY: A MODEL-BASED BURDEN-OF-ILLNESS ANALYSIS
Aug 11, 2026, 17:15 PM -
TARGETED LITERATURE REVIEW ASSESSING THE BURDEN OF PSEUDOMONAS AERUGINOSA COLONIZATION IN CHRONIC RESPIRATORY DISEASES
Aug 11, 2026, 17:15 PM -
HEALTH STATE UTILITIES ASSOCIATED WITH TREATMENT FOR TRANSFUSION DEPENDENT ß-THALASSEMIA IN FRANCE
Aug 11, 2026, 17:15 PM -
SETTING THE BAR WITHOUT A NUMBER: HTA AND GUIDELINE EXPECTATIONS FOR AI IN SLRS
Aug 11, 2026, 17:15 PM -
FROM NARRATIVE TO NUMBERS: A MEDICAL ANTHROPOLOGY MODEL FOR TRANSLATING PATIENT-BASED EVIDENCE INTO HTA-READY METRICS
Aug 11, 2026, 17:15 PM
